ReviewPharmaceuticals (Basel, Switzerland)2025

Bardoxolone Methyl: A Comprehensive Review of Its Role as a Nrf2 Activator in Anticancer Therapeutic Applications.

Valentina Schiavoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.